story of the week
Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression: A Subgroup Analysis of a Randomized Clinical Trial
JAMA Oncol 2016 May 12;[EPub Ahead of Print], S George, RJ Motzer, HJ Hammers, BG Redman, TM Kuzel, SS Tykodi, ER Plimack, J Jiang, IM Waxman, BI RiniRenal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.